Our work
Our aim is to ensure that research capacity and capabilities are in place to support the rapid initiation of scientific research in case of an outbreak.
GloPID-R is an international network of major research funders. Together, we coordinate a rapid research response when a pandemic or a severe epidemic strikes such as Zika in Brazil, plague in Madagascar or Ebola in the Democratic Republic of the Congo.
GloPID-R is also actively involved in systemic preparedness, connecting clinical trial networks, building a framework for data sharing and improving the rapid delivery of research funding.
Preparedness
GloPID-R prepares for upcoming outbreaks by analyzing the current state of knowledge and preparedness and identifying gaps as possible areas for funding. With our international partners, we identify priority areas and create working groups, develop videos and publications, and host workshops on these topics. Together, we are preparing the response to the next epidemic.
Discover the work GloPID-R is doing in advance of the next outbreak.
Clinical Trial Networks
Creating links between clinical trial networks and addressing challenges in capacity building or trial implementation in the midst of a crisis.
Data Sharing
Building the first international framework to facilitate data sharing during public health emergencies.
Long-Term Research
Identifying scientific gaps and addressing research challenges through a Long-Term Research Agenda.
Funding
Working to improve the rapid delivery of funds to research projects when a crisis strikes.
Response
GloPID-R anticipates upcoming epidemics and responds rapidly when an outbreak is of major concern. We facilitate research at the outset of an epidemic to understand and fight emerging or re-emerging pathogens, accelerate results and develop diagnostics, vaccines and therapeutics.
Discover the actions GloPID-R has taken in relation to recent outbreaks.
Plague
Bringing together scientific experts provide research recommendations to 2017 plague outbreak in Madagascar.
Yellow Fever
This group focused on effectiveness of fractional dosing in 2016 outbreak in Angola.
ZIKA
When the Zika virus struck, GloPID-R quickly mobilized to produce funding, publications and workshops.